arrow
C

Chiara Agrati

Saint Camillus International University of Health Sciences
H指数:48
被引数:7,777

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sars-Cov-2 spike protein and plasma from COVID-19 patients induce extracellular traps by myeloid-derived suppressor cells

Sars-Cov-2 spike protein和COVID-19患者的血浆可诱导髓源性抑制细胞形成胞外 traps

2025-11-180
OAAI
Impairment of Innate Immunity and Depletion of Vaccine-Induced Memory B and T Cells in the Absence of the Spleen

脾脏缺失导致的固有免疫受损及疫苗诱导的记忆B细胞和T细胞耗竭

2025-02-150
OAAI
Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients

先天性和SARS-CoV-2特异性适应性免疫应答动力学:在成功治疗COVID-19的中和单克隆抗体患者中

2025-02-010
PRE
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells

肿瘤衍生的g-csf在骨肉瘤模型中诱导免疫抑制微环境,降低对CAR.GD2 T细胞的反应

2024-12-180
OAAI
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study

mRNA SARS-CoV-2疫苗治疗儿童癌症后的体液和细胞免疫反应: 一项初步观察研究

HELIYON
IF3.6
2024-07-011
OAAI
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

根据先前的天花疫苗暴露和HIV感染,改良安卡拉痘苗暴露前疫苗的免疫原性和反应原性: 前瞻性队列研究

2024-02-018
OAAI
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV

HIV感染者mRNA疫苗接种后Anti-SARS-CoV-2免疫原性的长期评估

2023-11-225
OAAI
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine

年龄较大,中和抗体滴度较高以及常规DMARDs治疗与加强剂量Anti-SARS-CoV-2疫苗后类风湿性关节炎患者的突破性感染有关。

2023-11-024
OAAI
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naive Hospital Personnel

根据COVID-19-Naive医院人员mRNA第三剂疫苗接种后引发的免疫反应SARS-CoV-2突破性感染

2023-04-238
OAAI
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients
2023-04-012
OAAI
SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
2023-04-0110
OAAI
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients
2023-03-152
OA
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
2022-12-1516
OAAI
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
2022-09-243
OAAI
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
2022-08-2271
OAAI
SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak

新型冠状病毒肺炎爆发期间晚期HIV感染者的SARS-CoV-2特异性免疫反应和炎症状况

2022-07-2011
OAAI
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study

在脆弱患者中使用3剂信使RNA新型冠状病毒疫苗后的体液和T细胞免疫反应: 意大利VAX4FRAIL研究

2022-07-0729
OAAI